Acute Effects of Intravenous Administration of Polyunsaturated Fatty Acids on Blood Pressure and Heart Rate in U46619- and Noradrenaline-infused Rats
Autor: | Fumi Hatsuyama, Daisuke Chino, Satsuki Yuda, Keisuke Obara, Yoshio Tanaka, Yukiko Suzuki, Kyosuke Sato |
---|---|
Rok vydání: | 2017 |
Předmět: |
chemistry.chemical_classification
medicine.medical_specialty General Medicine Eicosapentaenoic acid Endocrinology Mean blood pressure Blood pressure chemistry Oral administration Docosahexaenoic acid Internal medicine medicine lipids (amino acids peptides and proteins) Sodium nitroprusside Unsaturated fatty acid medicine.drug Polyunsaturated fatty acid |
Zdroj: | British Journal of Pharmaceutical Research. 15:1-12 |
ISSN: | 2231-2919 |
DOI: | 10.9734/bjpr/2017/32604 |
Popis: | Experimental studies and epidemiological surveys have indicated that chronic oral administration of the n-3 polyunsaturated fatty acids (PUFAs) docosahexaenoic (DHA) or eicosapentaenoic (EPA) acids reduces blood pressure in hypertensive patients. However, few reports have described the acute blood pressure lowering effects of these PUFAs. In this study, we determined the acute effects of DHA and EPA on blood pressure of rats with increased blood pressure resulting from continuous injection of pressor substances. U46619 (a TXA2 receptor agonist) and noradrenaline (NA) were continuously infused (500 μg/kg/h each) into urethane-anesthetized male Wistar rats and produced sustained elevated mean blood pressure (MBP). In both U46619- and NA-infused rats, bolus administration of DHA (3–30 mg/kg, i.v.) reduced blood pressure in a dose-dependent manner, although the MBP reduction was greater in U46619-infused rats. Similarly, administration of EPA (3–30 mg/kg, i.v.) also induced a greater reduction in MBP of U46619-infused rats. In contrast, bolus administration of linoleic acid (3–30 mg/kg, i.v.), an n-3 type unsaturated fatty acid, failed to reduce blood pressure in all drug-infused rats. Finally, administration of the nitric oxide donor sodium nitroprusside (0.3–100 μg/kg, i.v.) showed a similar blood pressure drop in all drug-infused rats. These findings clearly indicate that both DHA and EPA induce acute blood pressure reduction in anesthetized rats, and suggest that the blood pressure drop is mediated via the TXA2 receptor. These characteristic blood pressure lowering effects of these PUFAs are likely to be useful for prevention and treatment of hypertension. |
Databáze: | OpenAIRE |
Externí odkaz: |